Activating more clinical trials that will successfully deliver new and improved drugs and medical devices to the public demands a modern clinical research workforce whose employers and other stakeholders can […]
Stakeholders in the matter can best leverage cutting-edge options for overcoming the inadequacies of current early talent hiring practices in the clinical research industry if they approach the challenge with […]
Panelists from a variety of organizations involved with clinical research will discuss how innovative approaches to workforce challenges and diversity, equity, and inclusion (DEI) issues are being implemented in their settings for the benefit of all stakeholders.
On this 19th Clinical Trials Day, I find myself pondering everything we still do not know, and everything we have yet to achieve in clinical research. From my many years of experience running clinical trial sites, I recognize the unfortunate reality that trials are too expensive and too slow – which has a real, human cost
Clinical research stands at the forefront of medical advancement, offering promising treatments and therapies to combat diseases and improve human health. Despite its noble objectives, the field faces numerous challenges to reduce the complexity of clinical trials notably due to an increasing demand for more data from regulatory and reimbursement stakeholders.